Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Estradiol Transdermal System market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Estradiol Transdermal Systemmarket, defines the market attractiveness level of Estradiol Transdermal System market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Estradiol Transdermal System industry, describes the types of Estradiol Transdermal System market, the applications of major players and the market size, and deeply analyzes the current situation of the global Estradiol Transdermal System market and the development prospects and opportunities of Estradiol Transdermal System industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Estradiol Transdermal System market in Chapter 13.
By Player:
Allergan
Noven Therapeutics
Perrigo Pharma International
Vertical Pharmaceuticals
Bayer
Mylan
Novartis
By Type:
0025 mg per day
00375 mg per day
005 mg per day
0075 mg per day
01 mg per day
By End-User:
Hot flashes
Prevention of postmenopausal osteoporosis
Treatment of hypoestrogenism
Moderate-to-severe vasomotor symptoms
Others
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Estradiol Transdermal System Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Estradiol Transdermal System Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Estradiol Transdermal System Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Estradiol Transdermal System Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Estradiol Transdermal System Market Analysis and Outlook to 2022
-
7.1 Global Estradiol Transdermal System Consumption (2017-2022)
-
7.2 United States Estradiol Transdermal System Consumption (2017-2022)
-
7.3 Europe Estradiol Transdermal System Consumption (2017-2022)
-
7.4 China Estradiol Transdermal System Consumption (2017-2022)
-
7.5 Japan Estradiol Transdermal System Consumption (2017-2022)
-
7.6 India Estradiol Transdermal System Consumption (2017-2022)
-
7.7 South Korea Estradiol Transdermal System Consumption (2017-2022)
8 Region and Country-wise Estradiol Transdermal System Market Analysis and Outlook to 2028
-
8.1 Global Estradiol Transdermal System Consumption Forecast (2022-2028)
-
8.2 United States Estradiol Transdermal System Consumption Forecast (2022-2028)
-
8.3 Europe Estradiol Transdermal System Consumption Forecast (2022-2028)
-
8.4 China Estradiol Transdermal System Consumption Forecast (2022-2028)
-
8.5 Japan Estradiol Transdermal System Consumption Forecast (2022-2028)
-
8.6 India Estradiol Transdermal System Consumption Forecast (2022-2028)
-
8.7 South Korea Estradiol Transdermal System Consumption Forecast (2022-2028)
9 Global Estradiol Transdermal System Market Outlook by Types and Applications to 2022
-
9.1 Global Estradiol Transdermal System Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global 0025 mg per day Consumption and Growth Rate (2017-2022)
-
9.1.2 Global 00375 mg per day Consumption and Growth Rate (2017-2022)
-
9.1.3 Global 005 mg per day Consumption and Growth Rate (2017-2022)
-
9.1.4 Global 0075 mg per day Consumption and Growth Rate (2017-2022)
-
9.1.5 Global 01 mg per day Consumption and Growth Rate (2017-2022)
-
9.2 Global Estradiol Transdermal System Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hot flashes Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Prevention of postmenopausal osteoporosis Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Treatment of hypoestrogenism Consumption and Growth Rate (2017-2022)
-
9.2.4 Global Moderate-to-severe vasomotor symptoms Consumption and Growth Rate (2017-2022)
-
9.2.5 Global Others Consumption and Growth Rate (2017-2022)
10 Global Estradiol Transdermal System Market Outlook by Types and Applications to 2028
-
10.1 Global Estradiol Transdermal System Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global 0025 mg per day Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global 00375 mg per day Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global 005 mg per day Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global 0075 mg per day Consumption Forecast and Growth Rate (2022-2028)
-
10.1.5 Global 01 mg per day Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Estradiol Transdermal System Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Hot flashes Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Prevention of postmenopausal osteoporosis Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Treatment of hypoestrogenism Consumption Forecast and Growth Rate (2022-2028)
-
10.2.4 Global Moderate-to-severe vasomotor symptoms Consumption Forecast and Growth Rate (2022-2028)
-
10.2.5 Global Others Consumption Forecast and Growth Rate (2022-2028)
11 Global Estradiol Transdermal System Import and Export Analysis (Top 5 Countries)
-
11.1 Global Estradiol Transdermal System Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Estradiol Transdermal System Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Estradiol Transdermal System Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Estradiol Transdermal System Market Competitive Analysis
-
14.1 Allergan
-
14.1.1 Allergan Company Details
-
14.1.2 Allergan Estradiol Transdermal System Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Allergan Estradiol Transdermal System Product and Service
-
14.2 Noven Therapeutics
-
14.2.1 Noven Therapeutics Company Details
-
14.2.2 Noven Therapeutics Estradiol Transdermal System Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Noven Therapeutics Estradiol Transdermal System Product and Service
-
14.3 Perrigo Pharma International
-
14.3.1 Perrigo Pharma International Company Details
-
14.3.2 Perrigo Pharma International Estradiol Transdermal System Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Perrigo Pharma International Estradiol Transdermal System Product and Service
-
14.4 Vertical Pharmaceuticals
-
14.4.1 Vertical Pharmaceuticals Company Details
-
14.4.2 Vertical Pharmaceuticals Estradiol Transdermal System Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Vertical Pharmaceuticals Estradiol Transdermal System Product and Service
-
14.5 Bayer
-
14.5.1 Bayer Company Details
-
14.5.2 Bayer Estradiol Transdermal System Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Bayer Estradiol Transdermal System Product and Service
-
14.6 Mylan
-
14.6.1 Mylan Company Details
-
14.6.2 Mylan Estradiol Transdermal System Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Mylan Estradiol Transdermal System Product and Service
-
14.7 Novartis
-
14.7.1 Novartis Company Details
-
14.7.2 Novartis Estradiol Transdermal System Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Novartis Estradiol Transdermal System Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Estradiol Transdermal System
-
Figure Estradiol Transdermal System Picture
-
Table Global Estradiol Transdermal System Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Estradiol Transdermal System Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Estradiol Transdermal System Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Estradiol Transdermal System Consumption by Country (2017-2022)
-
Figure United States Estradiol Transdermal System Consumption and Growth Rate (2017-2022)
-
Table Europe Estradiol Transdermal System Consumption and Growth Rate (2017-2022)
-
Figure China Estradiol Transdermal System Consumption and Growth Rate (2017-2022)
-
Figure Japan Estradiol Transdermal System Consumption and Growth Rate (2017-2022)
-
Figure India Estradiol Transdermal System Consumption and Growth Rate (2017-2022)
-
Figure South Korea Estradiol Transdermal System Consumption and Growth Rate (2017-2022)
-
Figure Global Estradiol Transdermal System Consumption Forecast by Country (2022-2028)
-
Figure United States Estradiol Transdermal System Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Estradiol Transdermal System Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Estradiol Transdermal System Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Estradiol Transdermal System Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Estradiol Transdermal System Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Estradiol Transdermal System Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global 0025 mg per day Consumption and Growth Rate (2017-2022)
-
Figure Global 00375 mg per day Consumption and Growth Rate (2017-2022)
-
Figure Global 005 mg per day Consumption and Growth Rate (2017-2022)
-
Figure Global 0075 mg per day Consumption and Growth Rate (2017-2022)
-
Figure Global 01 mg per day Consumption and Growth Rate (2017-2022)
-
Figure Global Hot flashes Consumption and Growth Rate (2017-2022)
-
Figure Global Prevention of postmenopausal osteoporosis Consumption and Growth Rate (2017-2022)
-
Figure Global Treatment of hypoestrogenism Consumption and Growth Rate (2017-2022)
-
Figure Global Moderate-to-severe vasomotor symptoms Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global 0025 mg per day Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global 00375 mg per day Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global 005 mg per day Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global 0075 mg per day Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global 01 mg per day Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hot flashes Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Prevention of postmenopausal osteoporosis Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Treatment of hypoestrogenism Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Moderate-to-severe vasomotor symptoms Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Estradiol Transdermal System Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Estradiol Transdermal System Export by Region (Top 5 Countries) (2017-2028)
-
Table Allergan (Foundation Year, Company Profile and etc.)
-
Table Allergan Estradiol Transdermal System Sales, Price, Value and Gross Profit (2017-2022)
-
Table Allergan Estradiol Transdermal System Product and Service
-
Table Noven Therapeutics (Foundation Year, Company Profile and etc.)
-
Table Noven Therapeutics Estradiol Transdermal System Sales, Price, Value and Gross Profit (2017-2022)
-
Table Noven Therapeutics Estradiol Transdermal System Product and Service
-
Table Perrigo Pharma International (Foundation Year, Company Profile and etc.)
-
Table Perrigo Pharma International Estradiol Transdermal System Sales, Price, Value and Gross Profit (2017-2022)
-
Table Perrigo Pharma International Estradiol Transdermal System Product and Service
-
Table Vertical Pharmaceuticals (Foundation Year, Company Profile and etc.)
-
Table Vertical Pharmaceuticals Estradiol Transdermal System Sales, Price, Value and Gross Profit (2017-2022)
-
Table Vertical Pharmaceuticals Estradiol Transdermal System Product and Service
-
Table Bayer (Foundation Year, Company Profile and etc.)
-
Table Bayer Estradiol Transdermal System Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bayer Estradiol Transdermal System Product and Service
-
Table Mylan (Foundation Year, Company Profile and etc.)
-
Table Mylan Estradiol Transdermal System Sales, Price, Value and Gross Profit (2017-2022)
-
Table Mylan Estradiol Transdermal System Product and Service
-
Table Novartis (Foundation Year, Company Profile and etc.)
-
Table Novartis Estradiol Transdermal System Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis Estradiol Transdermal System Product and Service
-
